https://ebookmass.com/product/diagnostic-imaging-
Instant digital products (PDF, ePub, MOBI) ready for you
Download now and discover formats that fit your needs...
Diagnostic Imaging: Gynecology 3rd Edition Akram M. Shaaban
https://ebookmass.com/product/diagnostic-imaging-gynecology-3rdedition-akram-m-shaaban/
ebookmass.com
Diagnostic Pathology: Molecular Oncology 2nd Edition Mohammad A Vasef Md
https://ebookmass.com/product/diagnostic-pathology-molecularoncology-2nd-edition-mohammad-a-vasef-md/
ebookmass.com
Imaging for Clinical Oncology [Radiotherapy in Practice] 2nd Edition Peter Hoskin
https://ebookmass.com/product/imaging-for-clinical-oncologyradiotherapy-in-practice-2nd-edition-peter-hoskin/
ebookmass.com
eTextbook 978-0134404769 International Relations
https://ebookmass.com/product/etextbook-978-0134404769-internationalrelations/
ebookmass.com
Sustainable Businesses in Developing Economies: SocioEconomic and Governance Perspectives Rajagopal
https://ebookmass.com/product/sustainable-businesses-in-developingeconomies-socio-economic-and-governance-perspectives-rajagopal/
ebookmass.com
Thorp and Covich's Freshwater Invertebrates: Keys to Nearctic Fauna 4th Edition James H. Thorp
https://ebookmass.com/product/thorp-and-covichs-freshwaterinvertebrates-keys-to-nearctic-fauna-4th-edition-james-h-thorp/
ebookmass.com
Rediscovering John Dewey: How His Psychology Transforms
Our Education 1st ed. Edition Rex Li
https://ebookmass.com/product/rediscovering-john-dewey-how-hispsychology-transforms-our-education-1st-ed-edition-rex-li/
ebookmass.com
Lehninger Principles of Biochemistry 8th edition David L Nelson
https://ebookmass.com/product/lehninger-principles-ofbiochemistry-8th-edition-david-l-nelson/
ebookmass.com
Organic Synthesis Using Biocatalysis 1st Edition Goswami
https://ebookmass.com/product/organic-synthesis-usingbiocatalysis-1st-edition-goswami/
ebookmass.com
https://ebookmass.com/product/bridgers-lost-duckie-found-by-daddybook-1-della-cain-kaytea-kat/
ebookmass.com
Shaaban Rezvani Chapman SECOND EDITION AkramM.Shaaban,MBBCh Professor
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
MaryamRezvani,MD
AssociateProfessorofRadiology
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
PhilipR.Chapman,MD
AssociateProfessor ChiefofNeuroradiologySection TheUniversityofAlabamaatBirmingham Birmingham,Alabama
Elsevier
1600JohnF.KennedyBlvd. Ste1800 Philadelphia,PA19103-2899
DIAGNOSTICIMAGING:ONCOLOGY,SECONDEDITION
Copyright©2020byElsevier.Allrightsreserved.
ISBN:978-0-323-66112-6
Nopartofthispublicationmaybereproducedortransmittedinanyformorbyanymeans,electronicormechanical, includingphotocopying,recording,oranyinformationstorageandretrievalsystem,withoutpermissioninwritingfrom thepublisher.Detailsonhowtoseekpermission,furtherinformationaboutthePublisher’spermissionspoliciesandour arrangementswithorganizationssuchastheCopyrightClearanceCenterandtheCopyrightLicensingAgency,canbe foundatourwebsite:www.elsevier.com/permissions.
ThisbookandtheindividualcontributionscontainedinitareprotectedundercopyrightbythePublisher(otherthanas maybenotedherein).
Notices Practitionersandresearchersmustalwaysrelyontheirownexperienceandknowledgein evaluatingandusinganyinformation,methods,compoundsorexperimentsdescribedherein. Becauseofrapidadvancesinthemedicalsciences,inparticular,independentverificationof diagnosesanddrugdosagesshouldbemade.Tothefullestextentofthelaw,noresponsibilityis assumedbyElsevier,authors,editorsorcontributorsforanyinjuryand/ordamagetopersonsor propertyasamatterofproductsliability,negligenceorotherwise,orfromanyuseoroperationof anymethods,products,instructions,orideascontainedinthematerialherein.
Previouseditioncopyrighted2011.
LibraryofCongressControlNumber:2019941286
PrintedinCanadabyFriesens,Altona,Manitoba,Canada
Contributing Authors JuliaR.Crim,MD
ChiefofMusculoskeletalRadiology ProfessorofRadiology UniversityofMissouriatColumbia Columbia,Missouri
AhmedEbadaSalem,MD
ClinicalFellow
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah AssistantLecturer AlexandriaUniversitySchoolofMedicine Alexandria,Egypt
ChrisHanrahan,MD,PhD
AdjunctAssociateProfessor DepartmentofRheumatology DepartmentofRadiologyandImagingSciences UniversityofUtahSchoolofMedicine SaltLakeCity,Utah
LeifJensen,MD
AssociateProfessor
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
MatthewB.Morgan,MD,MS
AssociateProfessorofRadiology DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
JeffreyOlpin,MD
ProfessorofRadiology
DepartmentofRadiologyandImagingSciences UniversityofUtah
SaltLakeCity,Utah
DouglasRogers,MD
AssistantProfessor
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
SherryS.Wang,MBBS AssistantProfessor
DepartmentofRadiologyandImagingSciences UniversityofUtah SaltLakeCity,Utah
Additional Contributing Authors WendieA.Berg,MD,PhD,FACR,FSBI
Preface In2018,theAmericanJointCommissiononCancer(AJCC)publishedthe8theditionoftheAJCCCancer StagingManual Immediatelyafterpublication,wequicklygottoworkonthe2ndeditionofDiagnostic Imaging:Oncology,thesinglemostup-to-dateandcomprehensivetextbookonradiologictumorstaging.
The8theditionbringsamultitudeofchangesthatdirectlyaffectradiologicimageevaluationandtumor staging.Almosteveryorgansystemhasseenwidespreadmodifications,andmoststagingschemes basedonthe7theditionarenowoutdatedandincorrect.Thiseditionfeatures7entirelynewstaging systemsandawiderangeofchangedornewstagingdefinitions.Changesincludesplittingofsome chaptersandmergingofothers.A“SummaryofChanges”tablehasbeenaddedtochaptersdetailing whatchangedbetweenthe7thand8theditions.
Eachlavishlyillustratedchapteroffersmultiplewaystoquicklyreviewaparticularcancer.Bulletedtext distillspertinentinformationtotheessentials.Referencetablesprovidequickaccesstodefinitionsfor TNMandAJCCprognosticgroupswithdetailedgraphicsforavisualreference.Over105updatedand newillustrationsfornewstagingclassificationshavebeenadded.High-qualityimagesdemonstratethe radiologicappearanceofpracticallyeverystageofeverytumor.Over2,000updatedimageswereadded, andallofthesevividimagesarefullycaptionedandannotatedtomaximizetheirillustrativepotential. Whether you are looking for routes of spread, imaging techniques for local staging, or treatment options,youwillfinditquicklyinthiseasy-to-useyetcomprehensivereference.Itisa“must-have”forany radiologistinvolvedintumorimaging.
AkramM.Shaaban,MBBCh Professor DepartmentofRadiologyandImagingSciences
UniversityofUtah
SaltLakeCity,Utah
Acknowledgments LEADEDITOR
NinaI.Bennett,BA
TEXTEDITORS
ArthurG.Gelsinger,MA
RebeccaL.Bluth,BA
TerryW.Ferrell,MS
MeggMorin,BA
IMAGEEDITORS
JeffreyJ.Marmorstone,BS
LisaA.M.Steadman,BS
MEDICALEDITORS
DouglasRogers,MD
AhmedEbadaSalem,MD
ILLUSTRATIONS
RichardCoombs,MS
LaneR.Bennion,MS
LauraC.Wissler,MA
ARTDIRECTIONANDDESIGN
TomM.Olson,BA
PRODUCTIONCOORDINATORS
EmilyC.Fassett,BA
JohnPecorelli,BS
Sections SECTION1: Head&Neck
SECTION2: Thorax
SECTION3: Breast
SECTION4: GastrointestinalSites
SECTION5: GenitourinarySites
SECTION6: GynecologicSites
SECTION7: MusculoskeletalSites
SECTION8: SystemicMalignancies
TABLEOFCONTENTS SECTION1:HEAD&NECK
4 LipandOralCavityCarcinoma
18
32
44
56
PhilipR.Chapman,MD
Oropharynx[p16(-)]Carcinoma
PhilipR.Chapman,MD
HypopharynxCarcinoma
PhilipR.Chapman,MD
HPV-Mediated[p16(+)]OropharyngealCarcinoma
PhilipR.Chapman,MD
NasopharynxCarcinoma
PhilipR.Chapman,MD
68 LarynxCarcinoma
90
PhilipR.Chapman,MD
NasalCavityandParanasalSinusesCarcinoma
PhilipR.Chapman,MD
106 MajorSalivaryGlandCarcinoma
PhilipR.Chapman,MD
126 DifferentiatedandAnaplasticThyroidCarcinoma
PhilipR.Chapman,MD
SECTION2:THORAX
148 LungCarcinoma
LeifJensen,MD
170 MalignantPleuralMesothelioma
LeifJensen,MD
184 ThymusCarcinoma
LeifJensen,MD
SECTION3:BREAST
196 BreastCarcinoma
MatthewB.Morgan,MD,MSandWendieA.Berg,MD, PhD,FACR,FSBI
SECTION4:GASTROINTESTINALSITES
224 EsophagusandEsophagogastricJunctionCarcinoma
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
248 StomachCarcinoma
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
266 SmallIntestineCarcinoma
MaryamRezvani,MD
280 AppendixCarcinoma
AkramM.Shaaban,MBBCh
296 ColonicCarcinoma
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
310 AnalCarcinoma
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
322 NeuroendocrineTumorsofStomach
AkramM.Shaaban,MBBCh
332
342
356
NeuroendocrineTumorsofDuodenumandAmpulla ofVater
AkramM.Shaaban,MBBCh
NeuroendocrineTumorsofJejunumandIleum
AkramM.Shaaban,MBBCh
NeuroendocrineTumorsofColonandRectum
AkramM.Shaaban,MBBCh
366 NeuroendocrineTumorsofAppendix
AkramM.Shaaban,MBBCh
374 RectalCarcinoma
DouglasRogers,MDandAhmedEbadaSalem,MD
388 GastrointestinalStromalTumor
404
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
HepatocellularCarcinoma
JeffreyOlpin,MD
420 GallbladderCarcinoma
AkramM.Shaaban,MBBCh
436 IntrahepaticBileDuctCarcinoma
MaryamRezvani,MD
450 PerihilarBileDuctCarcinoma
468
MaryamRezvani,MD
DistalBileDuctCarcinoma
MaryamRezvani,MD
480 AmpullaofVaterCarcinoma
AkramM.Shaaban,MBBCh
492 ExocrinePancreasCarcinoma
506
524
AkramM.Shaaban,MBBCh
NeuroendocrineTumorsofPancreas
AkramM.Shaaban,MBBCh
SECTION5:GENITOURINARYSITES
AdrenalCorticalCarcinoma
AkramM.Shaaban,MBBCh
536 PheochromocytomaandParaganglioma
AkramM.Shaaban,MBBCh
546 RenalCellCarcinoma
DouglasRogers,MD
566 RenalPelvisandUreterCarcinoma
AkramM.Shaaban,MBBCh
584 UrinaryBladderCarcinoma
AkramM.Shaaban,MBBCh
598 UrethralCarcinoma
AkramM.Shaaban,MBBCh
612 ProstateCarcinoma
JeffreyOlpin,MD
628 TestisCarcinoma
AkramM.Shaaban,MBBCh
TABLEOFCONTENTS SECTION6:GYNECOLOGICSITES
646 CorpusUteriCarcinoma
MaryamRezvani,MD
662 CorpusUteriSarcoma
MaryamRezvani,MD
674 CervixUteriCarcinoma
MaryamRezvani,MD
694 Ovary,FallopianTube,andPrimaryPeritoneal Carcinoma
AkramM.Shaaban,MBBCh
714 VaginalCarcinoma
AkramM.Shaaban,MBBCh
726 VulvarCarcinoma
MaryamRezvani,MD
738 GestationalTrophoblasticNeoplasms
AkramM.Shaaban,MBBCh
SECTION7:MUSCULOSKELETALSITES
750 PrimaryMalignantBoneTumor
JuliaR.Crim,MD
778 MultipleMyeloma
ChrisHanrahan,MD,PhD
784 SoftTissueSarcomaofExtremitiesandTrunk
JuliaR.Crim,MD
804 SoftTissueSarcomasofAbdominalandThoracic VisceralOrgans
AkramM.Shaaban,MBBCh
812 SoftTissueSarcomaofRetroperitoneum
SherryS.Wang,MBBS
SECTION8:SYSTEMICMALIGNANCIES
826 HodgkinandNon-HodgkinLymphomas
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
850 MelanomaofSkin
AhmedEbadaSalem,MDandAkramM.Shaaban,MBBCh
Shaaban Rezvani Chapman Head & Neck LipandOralCavityCarcinoma T|DefinitionofPrimaryTumor TCategory TCriteria
TX Primarytumorcannotbeassessed
Tis
T1
T2
T3
T4
T4a
T4b
Carcinomainsitu
Tumor≤2cm,≤5mmDOI;DOIisnottumorthickness
Tumor≤2cm,DOI>5mmand≤10mm; ortumor>2cmbut≤4cm,andDOI≤10mm
Tumor>4cmortumor≥10mmDOI,but<20mm
Moderatelyadvancedorveryadvancedlocaldisease
Moderatelyadvancedlocaldisease;T4aisdefinedasmoderatelyadvancedlocaldisease,tumorinvading adjacentstructuresonly(e.g.,throughcorticalboneofmandibleormaxilla,orinvolvesmaxillarysinusorskinof face)orextensivetumorwithbilateraltongueinvolvement&/orDOIlargerthan20mm
Veryadvancedlocaldisease;tumorinvadesmasticatorspace,pterygoidplates,orskullbase&/orencasesICA DOI=depthofinvasion;ICA=internalcarotidartery.
N|DefinitionofRegionalLymphNode:Clinical(cN)andPathological(pN) Regionallymphnodescannotbeassessed
Noregionallymphnodemetastasis
N1
N2
N2a
N2b
N2c
N3
N3a
N3b
PathologicalN(pN)
Metastasisinsingleipsilateralnode≤3cmandENE(-)
Metastasisinsingleipsilateralnodelargerthan3cmbutnotlargerthan6cmingreatestdimensionandENE(-); ormetastasesinmultipleipsilaterallymphnodes,nonelargerthan6cmingreatestdimensionandENE(-); orinbilateralorcontralaterallymphnodes,nonelargerthan6cmingreatestdimensionandENE(-)
Metastasisinsingleipsilaterallymphnodelargerthan3cmbutnotlargerthan6cmingreatestdimension,and ENE(-)
Metastasisinmultipleipsilaterallymphnodes,nonelargerthan6cmingreatestdimension,andENE(-)
Metastasisinbilateralorcontralaterallymphnodes,nonelargerthan6cmingreatestdimension,andENE(-)
Metastasisinlymphnodelargerthan6cmingreatestdimensionandENE(-); ormetastasisinanynode(s)andclinicallyovertENE(+)
Metastasisinlymphnodelargerthan6cmingreatestdimensionandENE(-)
Metastasisinanynode(s)andclinicallyovertENE(+)
NX Regionallymphnodescannotbeassessed
N0 Noregionallymphnodemetastasis
N1
N2
N2a
N2b
N2c
N3
N3a
N3b
Metastasisinsingleipsilaterallymphnode,3cmorsmalleringreatestdimensionENE(-)
Metastasisinsingleipsilaterallymphnode,3cmorsmalleringreatestdimensionandENE(+); or largerthan3cmbutnotlargerthan6cmingreatestdimensionandENE(-); or metastasesinmultipleipsilaterallymphnodes,nonelargerthan6cmingreatestdimensionandENE(-); orinbilateralorcontralaterallymphnodes,nonelargerthan6cmingreatestdimension,ENE(-)
Metastasisinsingleipsilateralorcontralaterallymphnode3cmorsmalleringreatestdimensionandENE(+); or singleipsilateralnodelargerthan3cmbutnotlargerthan6cmingreatestdimensionandENE(-)
Metastasisinmultipleipsilateralnodes,nonelargerthan6cmingreatestdimensionandENE(-)
Metastasisinbilateralorcontralaterallymphnodes,nonelargerthan6cmingreatestdimensionandENE(-)
Metastasisinlymphnodelargerthan6cmingreatestdimensionandENE(-); or insingleipsilateralnodelargerthan3cmingreatestdimensionandENE(+); or multipleipsilateral,contralateral,orbilateralnodesanywithENE(+)
Metastasisinlymphnodelargerthan6cmingreatestdimensionandENE(-)
Metastasisinsingleipsilateralnodelargerthan3cmingreatestdimensionandENE(+); or multipleipsilateral,contralateral,orbilateralnodesanywithENE(+)
Adesignationof U or L maybeusedforanyNcategorytoindicatemetastasisabovethelowerborderofthecricoid(U)orbelowthelowerborderofthe cricoid(L).Similarly,clinicalandpathologicalENEshouldberecordedasENE(-)andENE(+).
LipandOralCavityCarcinoma M|DefinitionofDistantMetastasis MCategory MCriteria
M0 Nodistantmetastasis
M1 Distantmetastasis
AJCC|PrognosticStageGroups WhenTis… AndNis… AndM
G|HistologicGrade GCategory
GDefinition
GX Cannotbeassessed
G1 Welldifferentiated
G2 Moderatelydifferentiated
G3 Poorlydifferentiated
AlltablesusedwiththepermissionoftheAmericanCollegeofSurgeons.Amin,M.B.,Edge,S.B.,Greene,F.L.,etal.(Eds.)AJCCCancerStaging Manual.8thEd.SpringerNewYork,2017.
SummaryofChanges Change
Mucosalportionoflipnowseparatedfromcutaneous (external)lip
Extrinsictonguemusculatureinvolvementnolongerused forT4
Detailsofchange
Externalportionsoflipsnowconsideredcutaneousstructuresforpurposesof classificationandstaging
ClinicalandpathologicalDOInowusedtoincreaseTcategory
Extranodalextensionisaddedasqualifierforupstaging disease ENEdefinestumorthathasmetastasizedtolymphnodeandthenprogressedwithin nodetopointatwhichnodecapsuleisbreached,andtumorextendsintosurrounding tissue;ENEcarrieshigherlikelihoodoflocalregionalrecurrenceanddistantmetastasis andcarriesworseprognosis
DOI=depthofinvasion;ENE=extranodaltumorextension.
LipandOralCavityCarcinoma GraphicillustratesT1diseaseoftheoraltongueandmucosallip asatumorſtthatis≤2cmanddepthofinvasion(DOI)≤5mm.
GraphicillustratesT3diseaseoftheoraltongueandlipasa tumorſtthatis>4cmingreatestdimensionoranytumorwith DOI>10but≤20mm.Imagingisgenerallymorehelpfulin patientswithlargerlesionsforevaluatingthicknessofthelesion andpossibleinvasionofunderlyingstructures.
GraphicillustratesclinicalT2diseaseoftheoraltongueandlip asatumorſt.T2isdefinedasatumor≤2cmwithDOI>5mm and≤10mmortumor>2cmbut≤4cm,withDOI≤10mm.
Sagittalgraphicillustratesadeeplyinvasivetumorſtinvading themandiblest.Frontaldrawingshowsthetumorinvadingthe skinoftheface.Eitherfindingissufficienttoclassifya carcinomaofthelipasT4a.
T1
T2
T3
T4a:Lip
LipandOralCavityCarcinoma T4a:OralCavity
Axialgraphicillustratesmoderatelyadvancedlocaldiseaseſt withalargeoraltonguecancerinvadingadjacentstructures.The tumorextendslaterallyandinvadesthemandible.Thereis alsodeepinvasionwithDOI>20mm(blackline).
Metastases,OrganFrequency Coronalgraphicillustratesveryadvancedlocaldiseasewiththe tumorinvadingthemasticatorspaceſt,pterygoidplates,and skullbasest.T4btumorsmayalsoencasetheinternalcarotid artery.
T4b
LipandOralCavityCarcinoma OVERVIEW GeneralComments
• AmericanJointCommitteeonCancer(AJCC)staging systemisusedtostageepithelialandminorsalivarygland cancersoforalcavity(OC)
•Thisclassificationis not usedforothertypesof malignanciesoforalcancer
○Nonepithelialtumorsoflymphoidtissue
○Nonepithelialtumorsofsofttissue,suchassarcoma
○Nonepithelialtumorsofbone/cartilage
○MucosalmelanomaofOC
○Cutaneouslipcarcinoma
•OCsquamouscellcarcinoma(SCCa)iscloselyassociated withexposuretotobaccoandalcohol
•ImaginginOCcarcinomasperformedmainlytoassesslocal extensionandregionalspread
○Clinicalexaminationisgenerallybetterthanradiological imagingforscreeningformucosallesionsandmore accurateforevaluationofmucosallesionsize
○Majorityofcarcinomasareimagedafterdiagnosishas beenmade
•Treatmentisgenerallyaimedatsurgicalresectionof primarylesion ±postoperativeadjuvanttherapy
Classification
•VastmajorityofOCmalignancies(90-95%)areSCCa
•MalignantsubtypesofOCSCCatumors
○BasaloidSCCa
○Spindlecellcarcinoma
○Adenosquamouscarcinoma
○Carcinomacuniculatum
○Verrucouscarcinoma
○Lymphoepithelialcarcinoma
○PapillarySCCa
○AcantholyticSCCa
•OCanatomicallybeginsatmucosal-linedportionsoflips andextendstooropharynx
○PosteriormarginofOCisdefinedbyjunctionofhardand softpalatesuperiorly,anteriortonsillarpillarslaterally, andcircumvallatepapillaeoftongueinferiorly
○Anatomicsubsitesincludemucosal-linedportionsoflips, alveolarridges,buccalmucosa,floorofmouth(FOM), oraltongue,hardpalate,andretromolartrigoneregions
PATHOLOGY
RoutesofSpread
• Macroscopiclocaltumorextensionlargelydependent on siteoforiginoftumor
○Mucosallip
–Tumorinvadessubmucosa,adjacentgingivalmucosa, skin,andadjacentmandibleormaxilla
○Buccalmucosa
–Tumorinvadessubmucosa,buccinatormuscle,and ultimately,buccalspace
–Tumorcanextendlaterallyintodeepsubcutaneous fatofcheek
–Canextendtogingivaandinvolvemaxillaormandible
–Largetumorscanextendtomasticatorspace
○Loweralveolarridge
–Extendssubmucosally,invadescortex,andthen invadesmarrowspaceofmandible
–Marrowspaceinvolvementcanleadtoinvasionof perineuriumofalveolarnerve
○Upperalveolarridge
–Invademaxillaryalveolarridge;caninvadehardpalate, maxillarysinus
○Retromolartrigone(orretromolargingiva)
–Tumorcanspreadlaterallyintobuccalspaceand masticatorspace
–Canspreadsuperiorlyalongpterygomandibularraphe
–Invadesmandibularbone
–Caninvolveinferioralveolarnerveandlingualnerve withperineuraltumorspread(PNTS)
○FOM
–Tumorcanspreaddeepintomusculatureoftongue, acrossmidline,laterallyintomandible,inferiorlyto hyoidbone
○Hardpalate
–Canextendlaterallytogingivalmucosa,deepthrough corticalboneofhardpalateintoinferiornasalcavityor maxillarysinus
–Perineuralextensionalongpalatinenervestopalatine groove
○Anterior2/3oftongue(oraltongue)
–Tendtoinvadetonguemusculatureprimarily(intrinsic andthenextrinsic)
–Canextendposteriorlytoglossotonsillarjunctionand laterallyoranteriorlyintoFOM
• Regionallymphaticspread
○Lymphnodemetastasesgenerallyfollowpredictable andorderlypatternofspread
○Ingeneral,spreadgoesfromuppertomiddletolower cervicalnodes
○Canceroflip(lowpotentialformetastases)
–Submental(levelIA)andsubmandibular(levelIB) nodes
○Cancerofalveolarridgeorhardpalate(lowpotentialfor metastases)
–Submandibular(levelIB)
–Jugular(levelsII-IV)
–Retropharyngeal(lesscommonly)
○Primarysiteclosertomidlineincreasesriskofbilateral spreadtocervicalnodes
○Anteriorsuperiormediastinalnodesconsideredregional nodes(levelVII);othermediastinalnodesconsidered distantmetastases
• Metastaticdisease
○Pulmonarymetastasis
○Skeletalandhepaticmetastasesarelesscommon
GeneralFeatures
•Comments
○>90%ofcancersinOCareSCCa,mostaremoderatelyor welldifferentiated
○MostcommonsubsitesofOCcancer:Tongue,FOM,and gingiva
•Genetics
○Oralcancershowsrelativelysmalleffectofgeneticand familialpredisposition
○MostSCCaofOChavemutationsinTP53gene
LipandOralCavityCarcinoma ○MostOCSCCaareconsideredgeneticallyunstable
•Etiology
○Tobaccouseconsideredmostcommonetiology
○Alcoholusage
○Alcoholandtobaccoactsynergistically
○Betelquidchewing
○Sunlightexposure
○Humanpapillomavirus(HPV)infectionlikelyplaysrolein smallpercentageofOCcancers
•Epidemiologycancer
○23,880estimatednewcasesinUSAin2010
○5,470estimateddeathsinUSAin2010
○OCSCCaismorecommoninmen
○OCcarcinomaismoreprevalentinelderly
–Meanageatpresentation:60years
○Overalldecreaseinincidencefrom1970sinUSA
–Largelyattributedtodecreasesinsmoking
○MoreprevalentinpartsofAsia
–Duetovariousformsoftobaccouse
–Consumptionofbetel-containingsubstances
•Associateddiseases
○Therearevarietyofpotentiallymalignant(premalignant) disordersofOCmucosa,includingleukoplakiaand erythroplakia
–Leukoplakiadefinedclinicallyas"whitepatch"or plaqueofmucosathatisnototherwisecharacterized clinicallyorpathologicallyasanyotherdisease
–Erythroplakiaisred,"velvety"patchofmucosathat cannotbeotherwisecharacterizedclinicallyor pathologicallyasbeingcausedbyanyothercondition
GrossPathology&SurgicalFeatures
•Resectionofprimarytumorallowsforpathologic evaluation,includingextentoflocalspread,depthof invasion(DOI),andpTdesignation
•Lymphnodedissectionallowsforpathologicevaluationof lymphnodes,evaluationforextranodalextension(ENE), andpNclassification
○Surgicallyresectednodesshouldbeinspectedfor presenceofENE
○ENErepresentsextensionofmetastatictumorwithin lymphnodesthroughlymphnodecapsuleintoadjacent tissue
–ENEmaybemicroscopic,≤2mmbeyondcapsule
–ENEmaybemajor,>2mmorgrossENE
•Pathologicstaging,whileimportant,doesnotsupersede clinicalstagingasprimarystagingtool
•Classicgrosspathology
○Centralmucosalulceration
○Tumorstendtobefirmandinfiltratedwithtanorwhite cutsurface
•Tumorcanbeendophytic,exophytic,orulcerated
MicroscopicPathology
•H&E
○MostOCSCCamoderatelytowelldifferentiated
○Well-differentiatedtumors
–Exhibitwell-differentiatedsquamouscells,generally polyhedral-shapedwithconspicuousintercellular bridges,andappearinginnests,cords,andislandsof cellswithpinkcytoplasmandroundnuclei
–Dyskeratoticcellsandkeratinpearlsareprominent
○Moderatelydifferentiatedtumor
–Composedofcordsorislandsofneoplasticatypical
epithelialcells,oblongoroval-shaped,which infiltratedtumoralstroma
–Nucleiofneoplasticcellshavevariousshapesand sizes,mosthypochromicwithlargenucleoli
•Specialstains
○p16andHPV
–Upto1/3ofOCSCCap16(+)
–However,insituhybridization(moresensitiveforhighriskHPV)indicates<10%arepositiveforHPV
–Asopposedtooropharynx,studieshaveshownno definitesurvivaladvantageinp16(+)OCSCCa comparedtop16(-)OCSCCa
•OtherhistologicfactorstobeconsideredincludeENE,DOI, PNTS,andlymphovascularinvasion
IMAGINGFINDINGS Detection
•Clinicalassessmentusuallymoreaccuratethanimagingfor mucosallesion(T1-T3)
•Imagingimportantfordeepextentandlymphnodes
• CT
○ApposedmucosalsurfacescanlimitabilitytoidentifyOC lesions
○Typically,primarylesionwillappearasnodularormasslikeareaofenhancementinvolvingmucosalsurface
–Enhancingtissuemaybepredominantlyinvasive, exophytic(protrudingintoOC),orcombinationof bothpatterns
–Largerlesionscanshowareasofnecrosis
○Occasionally,lesionsareulceratedanddemonstrate excavationofmucosawithlocalizedtissueloss
○Appearanceofprimarytumorwilldependonsiteof originoftumor,size,andextentoflocalinvasion
–Locationsincludelip,buccalmucosa,alveolarridges, FOM,hardpalate,anterior2/3tongue(oraltongue), retromolartrigone
○Coronalandsagittalreformattedimageshelpful
○Puffed-cheektechniqueisoftenusefulforevaluating buccalandbuccal-gingivalsulcallesions
○LimitationsofCECT
–Smalllesionsmaybeobviousclinicallybutmaybe difficulttoseparatefromnormalmucosaonCECT
–Apposedmucosalsurfacescanlimitabilitytoidentify OClesions
–DentalamalgamstreakartifactcanobscureOC anatomyandpathology
• MR
○MRisidealimagingmodalityinOC
–Multiplanarcapabilities+bettercontrastforprimary evaluation
–DentalamalgamartifactlessseverethanwithCT
–Superiormodalityinevaluatinghardpalatetumors
–Superiorillustrationoftumor-muscleinterfaceand perineuralextension
○T1WI
–Isointensetomuscle
–Lowsignalintensityofprimarytumor